|
WO2020210139A1
|
|
Pyrazolesulfonamides as antitumor agents
|
|
WO2020092100A1
|
|
Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereof
|
|
WO2019232319A1
|
|
Compositions and methods for inhibiting cd73
|
|
TW202003430A
|
|
Methods of reducing inflammation of the digestive system with inhibitors of HIF-2-alpha
|
|
EP3600273A1
|
|
Cd73 inhibitors and uses thereof
|
|
US2016362390A1
|
|
Tricyclic inhibitors of HIF-2-alpha and uses thereof
|
|
WO2016168510A1
|
|
Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
|
|
WO2016145236A1
|
|
Hif-2-alpha inhibitor polymorphs
|
|
EP3267792A1
|
|
Compositions for use in treating pulmonary arterial hypertension
|
|
US2018042884A1
|
|
Compositions for use in treating glioblastoma
|
|
WO2016144825A1
|
|
Aromatic compounds and uses thereof
|
|
WO2016144826A1
|
|
Substituted pyridines and uses thereof
|
|
WO2015175845A1
|
|
Benzimidazole derivatives and uses thereof
|
|
US2016368893A1
|
|
Cyclic sulfone and sulfoximine analogs and uses thereof
|
|
HUE045462T2
|
|
Aryl ethers and uses thereof
|
